Influential factors of treatment cost of antihypertensive drugs for hypertensive patient in community.
10.11817/j.issn.1672-7347.2015.03.010
- Author:
Ruihua FENG
1
,
2
;
Zengwu WANG
;
Yueying CUI
;
Xin WANG
;
Xiaowan WANG
Author Information
1. Department of Social Medicine and Health Service Management, School of Public Health, Central South University, Changsha 410078
2. Center for Health Policy and Management, China Academy of Medicine Sciences, Beijing 100020,China.
- Publication Type:Journal Article
- MeSH:
Antihypertensive Agents;
economics;
Blood Pressure;
China;
Community Health Services;
Health Care Costs;
Humans;
Hypertension;
economics
- From:
Journal of Central South University(Medical Sciences)
2015;40(3):291-297
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the influential factors of treatment cost of antihypertensive drugs for hypertensive patient in community.
METHODS:A total of 220 community health centers (CHCs) from 15 provinces were selected across China in view of geographical location, economic level and previous cooperative experience to implement standardized blood pressure management for hypertensive patients for 1 year, based on guidelines for prevention and control for hypertension in China (2009 Community-based revision). Baseline and follow-up information for each hypertensive patient under the care of these CHCs was collected. A total of 22 683 hypertensive patients in hypertension community standardization management were enrolled in this study. We used multivariate linear regression model to analyze the influential factors of treatment cost of antihypertensive drugs.
RESULTS:Cultural degree, regional distribution, medical security system, the blood pressure classification, complications, and treatment options were statistically significant independent variables.
CONCLUSION:In hypertension community standardization management, the blood pressure of hypertensive patients should be controlled in advance to reduce the economic burden, , the occurrence of complications should be reduced, and economic factors should also be considered when selecting a treatment option.